2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC2403
  



  

  
Submitter : 
  

  
Mrs. Dianna DeBarberie
  

  
Date & Time: 
  

  
12/01/2006 08:12:33
  



  

  
Organization : 
  

  
Mrs. Dianna DeBarberie
  



  

  
Category : 
  

  
Individual Consumer
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 RE: FDA DOCKET NUMBER:  2006D-0383

Guidance to Industry  for Development of Cell-Based Viral Vaccines



Dear Ladies and Gentlemen,



I am writing to voice my concern over the current and potential future use of cell lines derived from aborted fetuses.  This is an absolute outrage and I will not tolerate the pharmaceutical companies abuse of the human race to further their agenda in the name of "protecting the population".  



I respectfully write to you today to let you know that I vehemently oppose the use of these cell lines in order to protect us.  There are many alternative cell lines that can be used in place of these, and I believe that we should use them, so that all peoples with moral convictions will use them and not pose a threat to the rest of the population by NOT immunizing their children.  



As a mother of five children, I have not immunized my last child against the Rubella virus specifically for the above referenced reason.  So, as you can see, people will NOT vaccinate, if it interferes with our religious beliefs.



In the best interest of ALL people, I urge you to oppose the use of ALL cell lines derived from aborted fetuses, so that, together, we can morally eradicate all viruses from ALL nations.



Respectfully yours,



Dianna M DeBarberie

West Chester, PA



CC:  Secretary Michael O. Leavitt

     The U S Dept of Health and Human Services

     

     Julie L. Gerberding, Director

     Centers for Disease Control and Prevention